Fig. 3From: Evaluation of the EMulate Therapeutics Voyager’s ultra-low radiofrequency energy in murine model of glioblastomaTumor Weight – U87 Xenograft Study. Mean tumor weight of the excised tumors in the A1A-treated group were significantly less than that of the untreated control group (mean ± standard deviation on Day 28; untreated: 0.6 ± 0.1 g; A1A: 0.2 ± 0.2 g; *p < 0.001)Back to article page